CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2018. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,421,867 | -80.8% | 26,326 | -75.8% | 0.00% | -66.7% |
Q1 2024 | $7,411,923 | +585.6% | 108,743 | +529.7% | 0.00% | – |
Q4 2023 | $1,081,102 | -82.5% | 17,270 | -87.3% | 0.00% | -100.0% |
Q3 2023 | $6,183,480 | -2.3% | 136,230 | +20.8% | 0.00% | 0.0% |
Q2 2023 | $6,329,617 | +53727.9% | 112,747 | -56.6% | 0.00% | -57.1% |
Q1 2023 | $11,759 | +2280.4% | 259,977 | +2040.8% | 0.01% | – |
Q4 2022 | $494 | -99.9% | 12,144 | +26.4% | 0.00% | – |
Q3 2022 | $628,000 | -48.3% | 9,611 | -51.9% | 0.00% | -100.0% |
Q2 2022 | $1,215,000 | -71.2% | 20,000 | -70.2% | 0.00% | -66.7% |
Q1 2022 | $4,217,000 | -86.5% | 67,188 | -83.7% | 0.00% | -81.2% |
Q4 2021 | $31,325,000 | +26.2% | 413,366 | +86.5% | 0.02% | +6.7% |
Q3 2021 | $24,815,000 | +27.8% | 221,700 | +84.8% | 0.02% | +36.4% |
Q2 2021 | $19,417,000 | +19.7% | 119,939 | -9.9% | 0.01% | -8.3% |
Q1 2021 | $16,220,000 | +70.4% | 133,112 | +114.1% | 0.01% | +100.0% |
Q4 2020 | $9,521,000 | +184.2% | 62,185 | +36.4% | 0.01% | +20.0% |
Q2 2020 | $3,350,000 | -82.4% | 45,592 | -85.4% | 0.01% | -79.2% |
Q4 2019 | $19,029,000 | +335.8% | 312,433 | +193.3% | 0.02% | +242.9% |
Q3 2019 | $4,366,000 | +46.6% | 106,538 | +58.6% | 0.01% | +75.0% |
Q3 2018 | $2,979,000 | +33.3% | 67,179 | -29.4% | 0.00% | +33.3% |
Q4 2017 | $2,234,000 | +66.1% | 95,130 | +26.4% | 0.00% | +50.0% |
Q3 2017 | $1,345,000 | +154.3% | 75,272 | +128.1% | 0.00% | +100.0% |
Q2 2017 | $529,000 | +119.5% | 33,000 | +177.0% | 0.00% | 0.0% |
Q4 2016 | $241,000 | – | 11,913 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |